The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 748K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

17 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery of Potent and Selective Inhibitors of Wild-Type and Gatekeeper Mutant Fibroblast Growth Factor Receptor (FGFR) 2/3.EBI
Prelude Therapeutics
Exploiting binding-site arginines in drug design: Recent examples.EBI
Prelude Therapeutics
Nucleoside protein arginine methyltransferase 5 (PRMT5) inhibitors.EBI
Prelude Therapeutics
Discovery of Potent and Selective Covalent Protein Arginine Methyltransferase 5 (PRMT5) Inhibitors.EBI
Prelude Therapeutics
Thienopyridinyl and thiazolopyridinyl compounds useful as IRAK4 inhibitorsBDB
Bristol-Myers Squibb
TRIAZINE DIONE DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF IN MEDICINEBDB
Jiangsu Hengrui Pharmaceuticals
5-membered and bicyclic heterocyclic amides as inhibitors of ROCKBDB
Bristol-Myers Squibb
Fused imidazo-piperidine JAK inhibitorsBDB
Theravance Biopharma R&D Ip
FXR (NR1H4) modulating compoundsBDB
Gilead Sciences
Compositions for treating neurodegenerative diseasesBDB
Cognition Therapeutics
Ectonucleotidase inhibitors and methods of use thereofBDB
Calithera Biosciences
Methods of treating neurological, metabolic, and other disorders using enantiopure deuterium-enriched pioglitazoneBDB
Poxel
Inhibitors of cysteine proteases and methods of use thereofBDB
Pardes Biosciences
Kappa opioid receptor antagonists and products and methods related theretoBDB
Blackthorn Therapeutics
4-(3-cyanophenyl)-6-pyridinylpyrimidine mGlu5 modulatorsBDB
Heptares Therapeutics